Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

27.38
Delayed Data
As of 3:59pm ET
 +0.74 / +2.78%
Today’s Change
20.07
Today|||52-Week Range
42.48
-3.22%
Year-to-Date

Today’s Trading

Previous close26.64
Today’s open26.64
Day’s range26.39 - 27.47
Volume216,027
Average volume (3 months)319,729
Market cap$881.7M
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+68.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio98.4
Price/Sales11.37
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.20+2.82%
TBPHTheravance Biopharma...+0.45+2.17%
SUPNSupernus Pharmaceuti...-0.29-1.69%
ADROAduro Biotech Inc+0.32+2.47%
Data as of 3:59pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs